Literature DB >> 17357835

Haptoglobin polymorphisms are associated with Crohn's disease, disease behavior, and extraintestinal manifestations in Hungarian patients.

Maria Papp1, Peter Laszlo Lakatos, Karoly Palatka, Ildiko Foldi, Miklos Udvardy, Jolan Harsfalvi, Istvan Tornai, Zsuzsanna Vitalis, Tamas Dinya, Agota Kovacs, Tamas Molnar, Pal Demeter, Janos Papp, Laszlo Lakatos, Istvan Altorjay.   

Abstract

Functional differences and association with inflammatory disorders were found relating to three major haptoglobin (Hp) phenotypes. Our aim was to investigate Hp polymorphisms in Hungarian patients with Crohn's disease (CD). Four hundred sixty-eight CD patients and 384 healthy controls were examined. Hp phenotypes were determined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and immunoblotting of the sera. The frequency of the Hp(1) allele was significantly higher in CD (0.395; OR, 1.24; 95% CI, 1.02-1.52; P=0.03) compared to controls (0.345). In CD, Hp phenotype was associated with disease behavior (OR [Hp(2-1) vs other], 2.06; 95% CI, 1.29-3.28 for inflammatory behavior). Furthermore, an increased frequency of primary sclerosing cholangitis was observed in the Hp 2-2 compared to the Hp 1-1 phenotype (6.5% vs. 0.0%; P=0.039). We conclude that the Hp polymorphism is associated with CD, inflammatory disease behavior, and primary sclerosing cholangitis in Hungarian patients. Further studies are required to evaluate the significance of Hp polymorphisms in other populations from geographically diverse regions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17357835     DOI: 10.1007/s10620-006-9615-1

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.487


  29 in total

Review 1.  Crohn's disease.

Authors:  Fergus Shanahan
Journal:  Lancet       Date:  2002-01-05       Impact factor: 79.321

Review 2.  Clinical relevance of advances in genetics and pharmacogenetics of IBD.

Authors:  Tariq Ahmad; Cyrus Pesi Tamboli; Derek Jewell; Jean-Frédéric Colombel
Journal:  Gastroenterology       Date:  2004-05       Impact factor: 22.682

3.  Classification of inflammatory bowel disease.

Authors:  J E Lennard-Jones
Journal:  Scand J Gastroenterol Suppl       Date:  1989

4.  Distribution of haptoglobin phenotypes in a Korean population, using the semi-automated PhastSystem.

Authors:  S E Yang; W K Min; H Park; S Chun; J Nah; J Q Kim
Journal:  Ann Clin Biochem       Date:  2000-03       Impact factor: 2.057

5.  Accumulation of macrophages in primary sclerosing cholangitis.

Authors:  R G Cameron; L M Blendis; M G Neuman
Journal:  Clin Biochem       Date:  2001-05       Impact factor: 3.281

Review 6.  Primary sclerosing cholangitis.

Authors:  Jayant A Talwalkar; Keith D Lindor
Journal:  Inflamm Bowel Dis       Date:  2005-01       Impact factor: 5.325

7.  Haptoglobin polymorphism and mortality in patients with tuberculosis.

Authors:  I Kasvosve; Z A Gomo; E Mvundura; V M Moyo; T Saungweme; H Khumalo; V R Gordeuk; J R Boelaert; J R Delanghe; D De Bacquer; I T Gangaidzo
Journal:  Int J Tuberc Lung Dis       Date:  2000-08       Impact factor: 2.373

8.  Genetic polymorphism and TH1/TH2 orientation.

Authors:  N Bottini; F Gloria-Bottini; A Amante; P Saccucci; E Bottini
Journal:  Int Arch Allergy Immunol       Date:  2005-10-13       Impact factor: 2.749

9.  Haptoglobin polymorphism in Hungary.

Authors:  T Tauszik; L Szabó
Journal:  Gene Geogr       Date:  1992-12

10.  Association of extraintestinal manifestations of inflammatory bowel disease in a province of western Hungary with disease phenotype: results of a 25-year follow-up study.

Authors:  Laszlo Lakatos; Tunde Pandur; Gyula David; Zsuzsanna Balogh; Pal Kuronya; Arpad Tollas; Peter Laszlo Lakatos
Journal:  World J Gastroenterol       Date:  2003-10       Impact factor: 5.742

View more
  6 in total

1.  Zonulin transgenic mice show altered gut permeability and increased morbidity/mortality in the DSS colitis model.

Authors:  Craig Sturgeon; Jinggang Lan; Alessio Fasano
Journal:  Ann N Y Acad Sci       Date:  2017-04-19       Impact factor: 5.691

Review 2.  The role of Haptoglobin and its related protein, Zonulin, in inflammatory bowel disease.

Authors:  Tim Vanuytsel; Séverine Vermeire; Isabelle Cleynen
Journal:  Tissue Barriers       Date:  2013-12-10

Review 3.  Zonulin, a regulator of epithelial and endothelial barrier functions, and its involvement in chronic inflammatory diseases.

Authors:  Craig Sturgeon; Alessio Fasano
Journal:  Tissue Barriers       Date:  2016-10-21

4.  Gene expression changes associated with resistance to intravenous corticosteroid therapy in children with severe ulcerative colitis.

Authors:  Boyko Kabakchiev; Dan Turner; Jeffrey Hyams; David Mack; Neal Leleiko; Wallace Crandall; James Markowitz; Anthony R Otley; Wei Xu; Pingzhao Hu; Anne M Griffiths; Mark S Silverberg
Journal:  PLoS One       Date:  2010-09-30       Impact factor: 3.240

5.  Thrombospondin-1 type 1 repeats in a model of inflammatory bowel disease: transcript profile and therapeutic effects.

Authors:  Zenaida P Lopez-Dee; Sridar V Chittur; Bhumi Patel; Rebecca Stanton; Michelle Wakeley; Brittany Lippert; Anastasya Menaker; Bethany Eiche; Robert Terry; Linda S Gutierrez
Journal:  PLoS One       Date:  2012-04-03       Impact factor: 3.240

6.  Detecting non-allelic homologous recombination from high-throughput sequencing data.

Authors:  Matthew M Parks; Charles E Lawrence; Benjamin J Raphael
Journal:  Genome Biol       Date:  2015-04-08       Impact factor: 13.583

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.